Syngene Partners with Sapient Discovery, LLC to Expand Integrated Drug Discovery Offerings

BANGALORE, India--(BUSINESS WIRE)--Syngene International, a subsidiary of BIOCON Group, Indian biotechnology major, announced today that it will offer fully integrated drug discovery services by partnering with Sapient Discovery, a US-based Biotechnology Company. Syngene provides integrated Chemistry, Biology & Biologics services to support development programs of pharmaceutical & biotech companies worldwide on a platform of confidentiality and intellectual property protection.